Please login to the form below
diversity
This page shows the latest diversity news and features for those working in and with pharma, biotech and healthcare.
Boehringer Ingelheim and QUANTRO Therapeutics partner to develop drug candidates
Professor Norbert Kraut, global head of cancer research at Boehringer Ingelheim, said: “Transforming cancer care takes a diversity of minds.
Latest news
-
Bristol Myers Squibb launches initiative to ensure disability diversity in clinical trials
Bristol Myers Squibb (BMS) has launched the Disability Diversity in Clinical Trials (DDiCT) initiative to ensure equal access to clinical trials, ensuring all patient groups are ‘reflective of the real-world ... The initiative, which aligns with BMS’
-
Cannes Lions shows health creative is becoming an art form
Strategy, creativity, technology and diversity all converging around a problem and working hand-in-hand to solve it.
-
GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
The organisation’s proposal, the ‘HealthTree Equity and Diversity for Multiple Myeloma Program’ will aim to improve access, education and support for underserved communities in minority patients. ... Commenting on HealthTree’s winning proposal,
-
Shionogi Europe and NHS England agree on antibiotic subscription model
NICE considered the potential long-term population benefits of Fetcroja, including the ‘insurance/diversity’ value of having additional antimicrobial treatments available for the future, and the ‘enablement’ value linked with the
-
Cancer Research UK drives innovation with Cancer Research Horizons
this both in terms of volume, diversity and quality.
More from news
Approximately 7 fully matching, plus 154 partially matching documents found.
Latest Intelligence
-
Diversity, equity and inclusion
Diversity, equity and inclusion in the workplace. In 2022, there is a renewed focus on diversity, equity and inclusion (DE&I) in the workplace.
-
How Resonant’s innovation and creativity resolve healthcare communications challenges
Greater than the sum of our parts. Because of our agility, each of our companies can tap into the diversity of experience and professional capabilities within our team.
-
Diversity in Pharma: The Impact of COVID-19 on DE&I
Sandra Van de Cauter, Innovation Enabling Partner and Diversity and Inclusion Lead, F. ... Diversity only works when there is Inclusion, and Inclusion only happens when people truly feel safe.
-
Equipping our people leaders to drive an inclusive organisation
The rich diversity in our organisation equips us to bring the innovation and creativity needed to do just that. ... A good place to start is with the basics – what do we mean by diversity, inclusion or belonging?
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
We are seeing a rapid expansion in the use of mobile and patient-centric devices, exponential growth in the volume and diversity of life sciences data and acceleration in the use ... Identifying the right patients ensures better diversity and inclusion
More from intelligence
Approximately 8 fully matching, plus 71 partially matching documents found.
Latest appointments
-
ZPB Associates appoints Celine Parmentier as director of pharma services
This diversity of thinking and approach is fundamental to how we approach our work, and the creativity, energy and smart thinking that Celine brings to the team, amplifies this.”.
-
Paula Hensler joins Havas Just:: as scientific director
This is an exciting phase for scientific communicators. Post pandemic there is a spotlight on health inequalities and diversity.
-
Syneos Health Communications announces senior hires to Europe-based team
Most recently, she set up the internal and external diversity, equity and inclusion (DE&I) offering for a major medical education agency.
-
Evoke KYNE promotes Michael Grela to head of reputation and social impact
Grela will partner with Evoke KYNE’s leadership to highlight the agency’s Diversity, Equity and Inclusion efforts externally.
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
In addition, she has a deep understanding of the benefit of cultivating people, diversity and culture to strengthen internal collaboration and propel companies forward.
More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest from PMHub
-
Day in the life of an emotive Art Director
This diversity is one of the main things that I love about emotive – it never gets boring!
-
Evoke Kyne
Finalist – Comm uniqué Awards – Leadership Award for Action on Workforce Diversity.
-
Windrush Day
Innnovative Trials' Equality &Diversity committee raises awareness around Windrush Day and the Windrush generation. ... Each 22th April we celebrate Windrush day. For Innovative Trials' Equality &Diversity committee this is a special topic which is
-
Amplifying Opinions of Patients & Caregivers for Higher Quality of Care
Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey
-
Celebrating World Blood Donor Day
Today is world blood donor day and the Innovative Trials' Equality &Diversity committee have released a blog on the importance of blood donation including some key facts such as:.
More from PMHub
Approximately 75 fully matching, plus 70 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- Strategic commitment
- Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn
- AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug
- NHS England launches hepatitis C screening scheme to reach 2030 elimination goal
- Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer
- Valneva and Pfizer initiate phase 3 Lyme disease vaccine study
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- GSK/Merck KGgA cancer drug fails in third trial
- Chiesi Group's Trimbow wins European licence
- Roche shares new positive Ocrevus data for MS patients
- Roche’s Tecentriq demonstrates positive phase 3 results as a subcutaneous injection
- Using behavioural psychology to improve patient recruitment
PMHub
Viseven
Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
